Madelaine Beckett

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Polycyclic Aromatic Hydrocarbons

Top Venues

Substance abuse treatment, prevention, and policy

European journal of haematology

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Jan Dutz, Kun Huang
Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients. RMD open 10 (1) (2024)
Madelaine Beckett, Caroline Spaner, Mariam Goubran, John Wade, Juan Antonio Aviña-Zubieta, Audi Setiadi, Lori B Tucker, Kamran Shojania, Sheila Au, Andre Mattman, Agnes Y Y Lee, David C Fajgenbaum, Luke Y C Chen
CRP and sCD25 help distinguish between adult-onset Still's disease and HLH. European journal of haematology (2024)
Madelaine Beckett, Julia Tan, Evelyne Bonnardeaux, Jan P Dutz, Kamran Shojania, Fergus To, Anthony Obrzut, J Aviña-Zubieta, Kun Huang
Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients. Rheumatology (Oxford, England) (2023)
Madelaine Beckett, Ramm Hering, Karen A Urbanoski
Inpatient care provider perspectives on the development and implementation of an addiction medicine consultation service in a small urban setting. Substance abuse treatment, prevention, and policy 17 (1) (2022)